UPDATE: Amneal Pharmaceuticals (AMRX) Tops Q4 EPS by 3c, Revenues Beat; Offers FY20 Revenue Guidance Above Consensus, Provides FY20 EPS Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- US stock futures mixed as Apple slides, midterms loom
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
| AmerElite Solutions, Inc. New (NASDAQ: AMRX) | Delayed: 20.44 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $20.44 | 52 Week High | $0.19 | |||
| Open | $20.44 | 52 Week Low | $0.07 | |||
| Day High | $20.44 | P/E | N/A | |||
| Day Low | $20.44 | EPS | $-0.01 | |||
| Volume | 958 | |||||
